首页> 外文期刊>Nephron >Urinary complement factor h in renal disease.
【24h】

Urinary complement factor h in renal disease.

机译:肾脏疾病中的尿补体因子h。

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Complement factor H (hCFH) plays a key inhibitory role in the control of the alternative complement pathway. We examined whether urinary hCFH (U-hCFH) levels is useful as an indirect indicator of renal damage. Methods: Urine samples were obtained from 104 patients with renal disease. Urine was collected with 10 mM EDTA and U-hCFH levels were measured using the BTA TRAK Assay Kit. Results: In the 62 patients with nephritis, the levels of U-hCFH were elevated (range 15-52,198 U/ml) over the normal range (0-14 U/ml). U-hCFH levels of patients with chronic renal failure, lupus nephritis, membranoproliferative glomerulonephritis, focal glomerulosclerosis were higher than that of IgA nephropathy patients (p < 0.05). In the patients with minimal change disease, showed high levels of U-hCFH during the nephrotic syndrome. U-hCFH was correlated significantly with urinary protein and urinary N-acetyl-beta-D-glucosaminidase. Conclusion: We demonstrated that U-hCFH was detected in the urine of nephritis patients.
机译:背景:补体因子H(hCFH)在替代补体途径的控制中起着关键的抑制作用。我们检查了尿hCFH(U-hCFH)水平是否可作为肾脏损害的间接指标。方法:从104例肾病患者中获取尿液样本。用10 mM EDTA收集尿液,并使用BTA TRAK分析试剂盒测量U-hCFH水平。结果:62例肾炎患者中,U-hCFH水平升高(15-52,198 U / ml),超过正常范围(0-14 U / ml)。慢性肾功能衰竭,狼疮性肾炎,膜增生性肾小球肾炎,局灶性肾小球硬化患者的U-hCFH水平高于IgA肾病患者(p <0.05)。在病变最小的患者中,在肾病综合征期间显示高水平的U-hCFH。 U-hCFH与尿蛋白和尿N-乙酰基-β-D-氨基葡萄糖苷酶显着相关。结论:我们证明在肾炎患者的尿液中检测到U-hCFH。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号